ATE214939T1 - Behandlung von neurologischen zuständen durch eine interleukin-i-inhibierende verbindung - Google Patents
Behandlung von neurologischen zuständen durch eine interleukin-i-inhibierende verbindungInfo
- Publication number
- ATE214939T1 ATE214939T1 AT92922537T AT92922537T ATE214939T1 AT E214939 T1 ATE214939 T1 AT E214939T1 AT 92922537 T AT92922537 T AT 92922537T AT 92922537 T AT92922537 T AT 92922537T AT E214939 T1 ATE214939 T1 AT E214939T1
- Authority
- AT
- Austria
- Prior art keywords
- interleukin
- treatment
- pct
- inhibiting compound
- neurological conditions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919123161A GB9123161D0 (en) | 1991-10-31 | 1991-10-31 | Treatment of neurological conditions |
GB919125670A GB9125670D0 (en) | 1991-11-30 | 1991-11-30 | Treatment of neurogical conditions |
PCT/GB1992/002023 WO1993008820A1 (en) | 1991-10-31 | 1992-11-02 | Treatment of neurological conditions by an interleukin-1 inhibiting compound |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE214939T1 true ATE214939T1 (de) | 2002-04-15 |
Family
ID=26299779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92922537T ATE214939T1 (de) | 1991-10-31 | 1992-11-02 | Behandlung von neurologischen zuständen durch eine interleukin-i-inhibierende verbindung |
Country Status (10)
Country | Link |
---|---|
US (1) | US6090775A (de) |
EP (1) | EP0610336B1 (de) |
JP (1) | JP3623501B2 (de) |
AT (1) | ATE214939T1 (de) |
AU (3) | AU2884592A (de) |
CA (1) | CA2122596C (de) |
DE (1) | DE69232516T2 (de) |
DK (1) | DK0610336T3 (de) |
ES (1) | ES2173871T3 (de) |
WO (2) | WO1993008819A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
ATE270550T1 (de) * | 1995-04-07 | 2004-07-15 | Teijin Ltd | Wirkstoff zum schutz für organ oder gewebe |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US20030040660A1 (en) * | 2001-08-27 | 2003-02-27 | George Jackowski | Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein |
WO2003022213A2 (en) * | 2001-09-06 | 2003-03-20 | Board Of Regents, The University Of Texas System | Therapeutic treatments for spinal cord injury via blockade of interleukin-1 receptor |
EP1863847A2 (de) * | 2004-12-02 | 2007-12-12 | Domantis Limited | Anti-il-1r1 antikörper und deren therapeutische verwendung |
BRPI0619224A2 (pt) * | 2005-12-01 | 2017-06-20 | Domantis Ltd | monômero de anticorpo de domínio, ligando, ácidos nucleicos isolado e recombinante, vetor, célula hospedeira, método para produzir um monômero de dab de ligando, composição farmacêutica, dispositivo de liberação de medicamento, uso de um monômero de anticorpo de domínio, e, método para tratar uma doença inflamatória, artrite ou doença respiratória |
AU2010203425B2 (en) * | 2009-01-09 | 2015-04-09 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of corneal disorders |
EP2598526B1 (de) | 2010-07-29 | 2018-09-05 | Eleven Biotherapeutics, Inc. | Chimäre il-1 rezeptor typ i agonisten und antagonisten |
DK2968468T3 (en) | 2013-03-13 | 2021-07-26 | Buzzard Pharmaceuticals AB | Chimeric cytokine formulations for ocular delivery |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965271A (en) * | 1986-12-31 | 1990-10-23 | Hoechst Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
IL100535A (en) * | 1986-12-31 | 1994-05-30 | Hoechst Roussel Pharma | Pharmaceutical preparations containing a history of xanthine to relieve disease states |
HU203198B (en) * | 1987-10-26 | 1991-06-28 | Sandoz Ag | Process for producing pharmaceutical compositions having immunity-inhibiting, monokin-, particularly interleukin-1-inhibiting effect |
AU5921890A (en) * | 1989-06-13 | 1991-01-08 | Smithkline Beecham Corporation | Monokine activity interference |
AU649245B2 (en) * | 1990-04-02 | 1994-05-19 | Amgen, Inc. | Methods for treating interleukin-1 mediated diseases |
-
1992
- 1992-11-02 CA CA002122596A patent/CA2122596C/en not_active Expired - Lifetime
- 1992-11-02 AU AU28845/92A patent/AU2884592A/en not_active Abandoned
- 1992-11-02 DK DK92922537T patent/DK0610336T3/da active
- 1992-11-02 JP JP50826093A patent/JP3623501B2/ja not_active Expired - Lifetime
- 1992-11-02 ES ES92922537T patent/ES2173871T3/es not_active Expired - Lifetime
- 1992-11-02 EP EP92922537A patent/EP0610336B1/de not_active Expired - Lifetime
- 1992-11-02 US US08/232,167 patent/US6090775A/en not_active Expired - Lifetime
- 1992-11-02 WO PCT/GB1992/002019 patent/WO1993008819A1/en active Application Filing
- 1992-11-02 WO PCT/GB1992/002023 patent/WO1993008820A1/en active IP Right Grant
- 1992-11-02 AT AT92922537T patent/ATE214939T1/de not_active IP Right Cessation
- 1992-11-02 DE DE69232516T patent/DE69232516T2/de not_active Expired - Lifetime
- 1992-11-02 AU AU28041/92A patent/AU2804192A/en not_active Abandoned
-
1996
- 1996-12-24 AU AU76482/96A patent/AU7648296A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6090775A (en) | 2000-07-18 |
AU7648296A (en) | 1997-02-13 |
DK0610336T3 (da) | 2002-07-22 |
JPH07505608A (ja) | 1995-06-22 |
WO1993008820A1 (en) | 1993-05-13 |
EP0610336B1 (de) | 2002-03-27 |
JP3623501B2 (ja) | 2005-02-23 |
DE69232516D1 (de) | 2002-05-02 |
ES2173871T3 (es) | 2002-11-01 |
WO1993008819A1 (en) | 1993-05-13 |
AU2804192A (en) | 1993-06-07 |
CA2122596C (en) | 2008-06-03 |
CA2122596A1 (en) | 1993-05-13 |
EP0610336A1 (de) | 1994-08-17 |
DE69232516T2 (de) | 2002-10-31 |
AU2884592A (en) | 1993-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
ATE350060T1 (de) | Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten | |
ATE387215T1 (de) | Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff | |
ES2108120T3 (es) | Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf. | |
ATE214939T1 (de) | Behandlung von neurologischen zuständen durch eine interleukin-i-inhibierende verbindung | |
DK0697019T3 (da) | Risperidon pamoater | |
DE69118388D1 (de) | Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung | |
ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
KR880011197A (ko) | 위장장해를 치료하기 위한 조성물 및 방법 | |
RU94031161A (ru) | Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов | |
DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
DE69935670D1 (de) | Behandlung von dyskinesie durch mu-selektive opioidantagonisten | |
DK0636027T3 (da) | Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati | |
TR199701497T1 (xx) | Beyin �demini �nleyen terkip. | |
ITMI920955A1 (it) | Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili | |
ATE185071T1 (de) | Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms | |
MX9304075A (es) | Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos. | |
DE59303446D1 (de) | Neue bis-phenyl-hexene | |
ES2144452T3 (es) | Medicamento para el tratamiento de infecciones protozoarias provocadas por babesia. | |
DK0722325T3 (da) | Præparat til behandling eller forebyggelse af herpes | |
EP0645963A4 (de) | ||
EP0505389A4 (en) | Antiparasitic composition for animal use | |
NO921525L (no) | L-alfa-glyserofosforyl-d-myo-inositol for behandling av perifere nervelidelser og hjernelidelser | |
ATE333287T1 (de) | Prophylaxe und behandlung von autoimmunen entmyelinisierungserkrankungen durch fas- antagonisten | |
ES2098119T3 (es) | Nuevas triazoloquinazolinas, su obtencion y empleo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |